Morgan Stanley Maintains Overweight on argenx, Lowers Price Target to $510
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Matthew Harrison maintains an Overweight rating on argenx (NASDAQ:ARGX) but lowers the price target from $515 to $510.
May 28, 2024 | 5:21 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley's analyst Matthew Harrison maintains an Overweight rating on argenx but lowers the price target from $515 to $510. This suggests continued confidence in the stock's performance, albeit with slightly tempered expectations.
The Overweight rating indicates a positive outlook on argenx, but the slight reduction in the price target suggests a minor adjustment in expectations. This is likely to have a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100